HomeCompareUSYNF vs MRK

USYNF vs MRK: Dividend Comparison 2026

USYNF yields 226.76% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 USYNF wins by $251.56M in total portfolio value
10 years
USYNF
USYNF
● Live price
226.76%
Share price
$0.88
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$251.62M
Annual income
$134,733,455.30
Full USYNF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — USYNF vs MRK

📍 USYNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUSYNFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, USYNF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
USYNF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

USYNF
Annual income on $10K today (after 15% tax)
$19,274.38/yr
After 10yr DRIP, annual income (after tax)
$114,523,437.01/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, USYNF beats the other by $114,514,840.29/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of USYNF + MRK for your $10,000?

USYNF: 50%MRK: 50%
100% MRK50/50100% USYNF
Portfolio after 10yr
$125.84M
Annual income
$67,371,784.54/yr
Blended yield
53.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

USYNF
No analyst data
Altman Z
1.3
Piotroski
7/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

USYNF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUSYNFMRK
Forward yield226.76%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$251.62M$57.7K
Annual income after 10y$134,733,455.30$10,113.78
Total dividends collected$238.69M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: USYNF vs MRK ($10,000, DRIP)

YearUSYNF PortfolioUSYNF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$33,376$22,675.74$11,213$373.04+$22.2KUSYNF
2$106,443$70,730.79$12,667$512.06+$93.8KUSYNF
3$324,713$210,819.25$14,439$708.14+$310.3KUSYNF
4$948,492$601,048.96$16,640$988.16+$931.9KUSYNF
5$2,655,703$1,640,816.23$19,432$1,394.07+$2.64MUSYNF
6$7,135,206$4,293,603.76$23,057$1,992.90+$7.11MUSYNF
7$18,415,824$10,781,153.60$27,889$2,894.79+$18.39MUSYNF
8$45,710,485$26,005,554.09$34,518$4,286.29+$45.68MUSYNF
9$109,236,565$60,326,346.04$43,912$6,494.35+$109.19MUSYNF
10$251,616,580$134,733,455.30$57,714$10,113.78+$251.56MUSYNF

USYNF vs MRK: Complete Analysis 2026

USYNFStock

Unisync Corp., through its subsidiaries, manufactures and distributes garments in Canada. It operates in two segments, Peerless Garments LP and Unisync Group Limited. The company provides duty gear, footwear, and other accessories to fire, emergency medical services, and police and security sectors under the Carleton brand name; and service wear shirts, pants, and ties for law enforcement, fire, emergency medical, security, and correctional personnel under the Rapier brand name. It also offers professional workwear, insulated coverall, rugged workwear, outerwear, and rainwear apparel, as well as flame-resistant and safety clothing under the Hammill brand name. In addition, the company provides a line of flame-resistant work clothing under the DewLine Coveralls brand name; leatherwear; cold/wet weather outerwear garments to government organizations, including the armed forces, parks and forestry staff, RCMP, and other users under the Parkas brand name; stealth suits to various DND departments, paramilitary, police departments, and companies within the oil industry under the Gore-Tex brand name; and body measurement services under the Best-Fit name. Further, it designs, manufactures, and distributes corporate, public safety, and military uniforms under the Red the Uniform Tailor brand name; and offers corporate apparel under the York brand name, as well as public safety, and security and tactical products. The company was formerly known as ComWest Enterprise Corp. and changed its name to Unisync Corp. in August 2014. Unisync Corp. was founded in 1929 and is headquartered in Vancouver, Canada.

Full USYNF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this USYNF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

USYNF vs SCHDUSYNF vs JEPIUSYNF vs OUSYNF vs KOUSYNF vs MAINUSYNF vs JNJUSYNF vs ABBVUSYNF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.